Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alimak Group Proxy Solicitation & Information Statement 2026

Mar 30, 2026

2997_rns_2026-03-30_892184ff-1f6d-4994-8892-2d3f4d849835.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

ALIMAK GROUP

Press release

30 March, 2026

Annual General Meeting in Alimak Group AB

The Board of Alimak Group AB has resolved to convene an Annual General Meeting to be held on Wednesday, May 6, 2026. More detailed information about the contents of the proposals may be obtained from the complete notice to the Annual General Meeting below.

The notice will be published in the Swedish Official Gazette (Post- och Inrikes Tidningar) and on the Company's website within the next few days.

NOTICE OF ANNUAL GENERAL MEETING IN ALIMAK GROUP AB (PUBL)

The Annual General Meeting of Alimak Group AB (publ) will be held on Wednesday, May 6, 2026 at 3:00 pm at Klara Strand, S:ta Clara, Klarabergsviadukten 90, in Stockholm. Registration begins at 2:30 pm. Light refreshments will be served after the meeting.

RIGHT TO ATTEND AND NOTIFICATION TO THE COMPANY

Anyone wishing to attend the meeting must

(i) be entered as a shareholder in the share register kept by Euroclear Sweden AB as of Monday, April 27, 2026,
(ii) give notice to the company of their intention to attend no later than Wednesday, April 29, 2026.

Notification of attendance may be given in writing to the company at the address Årsstämma i Alimak Group AB, c/o Euroclear Sweden AB, PO Box 191, 101 23 Stockholm, Sweden or by telephone on +46 (0)8 402 92 08 weekdays between 9:00 am and 4:00 pm or on the company's website: www.alimakgroup.com. When giving notification please state your name or company name, personal ID or company registration number, address and daytime telephone number. The registration procedure described above also applies to registration for any advisors. See below for further information on the processing of personal data.

NOMINEE REGISTERED SHARES

To be entitled to attend the meeting, holders of nominee registered shares must instruct the nominee to have the shares registered in the holder's own name, so that the holder is entered in the share register kept by Euroclear Sweden AB as of Wednesday, April 29, 2026. Registration in this way may be temporary.

PROXY AND PROXY FORM

Anyone who does not attend the meeting in person may exercise their voting rights at the meeting via a proxy in possession of a signed and dated form of proxy. Forms of proxy are available on the


company's website: www.alimakgroup.com. The form of proxy may also be obtained from the company or be ordered over the telephone using the number above. If the proxy is issued by a legal entity, a copy of their registration certificate or equivalent documentary authority must be attached. The proxy must have been issued within the past year unless a longer period of validity is specified on the form of proxy, subject to a maximum of five (5) years. To facilitate entry to the meeting, forms of proxy, registration certificates and other documentary authority must be received by the company in good time before the meeting.

PROPOSED AGENDA

  1. Opening of the meeting
  2. Election of Chair of the meeting
  3. Preparation and approval of voting list
  4. Approval of the agenda
  5. Election of one or two persons to approve the minutes
  6. Examination of whether the meeting has been duly convened
  7. CEO's address
  8. Presentation of the annual and sustainability report, the consolidated accounts, the auditor's report on the annual accounts and consolidated accounts, and also the auditor's report on the sustainability statements
  9. Resolution on:
    a) adoption of the profit and loss account and balance sheet, and also the consolidated profit and loss account and consolidated balance sheet;
    b) allocation of the company's results in accordance with the adopted balance sheet and determination of the record day for dividend; and
    c) discharge from liability towards the company for the Directors and the CEO for the financial year 2025.
  10. Resolution on number of Directors and number of auditors
  11. Resolution on Directors' fees and auditor's fees
  12. Election of Directors and Chair of the Board
  13. Election of auditor
  14. Resolution regarding the Nomination Committee
  15. Resolution on approval of Remuneration Report
  16. Resolution on guidelines for salary and other remuneration
  17. Resolution on call option program 2026
  18. Resolution on:
    a) authorisation for the Board to resolve on acquisition of own shares;
    b) authorisation for the Board to resolve on transfer of own shares; and
    c) transfer of own shares to participants in call option program 2026.
  19. Closing of the meeting

RESOLUTIONS PROPOSED BY THE NOMINATION COMMITTEE

The Nomination Committee for the Annual General Meeting 2026 comprises the following members: Ossian Ekdahl, Investment AB Latour (Chair of the Nomination Committee); Francisco De Juan, Alantra EQMC Asset Management; Jakob Rikwide, representing Bolero Holdings SARL; and Johan Hjertensson, Chair of the Board of Alimak Group AB.

The Nomination Committee presents the following proposals for the meeting:

Election of Chair of the meeting (item 2)


The Nomination Committee proposes that Johan Hjertonsson, or if he is prevented from attending, the person the Nomination Committee proposes in his place, be elected to Chair the meeting.

Resolution on number of Directors and number of auditors (item 10)

The Nomination Committee proposes that the Board should be composed of seven (7) Directors elected by the meeting, with no alternates, for the period until the end of the next Annual General Meeting. The Nomination Committee proposes that the company shall have one (1) auditor, with no alternate.

Resolution on Directors' fees and auditor's fees (item 11)

The Nomination Committee proposes that the fee to the Directors for the period up to and including the Annual General Meeting 2027 will be paid as follows. The Chair of the Board will receive SEK 1,150,000 (previously SEK 1,035,000), and the other Directors elected by the meeting will receive SEK 455,000 (previously SEK 414,000) each. However, no fee shall be paid to Directors who are employed by the company. In addition, it is proposed that SEK 200,000 (previously SEK 180,000) is payable to the Chair of the Audit Committee and SEK 110,000 (previously SEK 100,000) to other members of the Audit Committee, SEK 110,000 (previously SEK 100,000) to the Chair of the Remuneration Committee, and SEK 65,000 (previously SEK 60,000) to other members of the Remuneration Committee.

Board members, who do not previously have corresponding holdings, are expected over a five-year period, to successively acquire and maintain a holding of shares in Alimak at a market value corresponding to at least one (1) year's remuneration to the Board of Directors before tax, excluding fees for committee work.

Fees will be paid to the auditor in accordance with approved invoices.

Election of Directors and Chair of the Board (item 12)

The Nomination Committee proposes re-election of Tomas Carlsson, Petra Einarsson, Heléne Mellquist, Dr Annette Rinck, Sven Törnkvist and Ole Kristian Jødahl (CEO) as Directors, and proposes Olof Stålnacke as new Director. Johan Hjertonsson and Helena Nordman-Knutson have declined re-election. The Nomination Committee proposes that Heléne Mellquist be elected as Chair of the Board.

Olof Stålnacke has served as CFO of Sweco Group, CFO of Coor Service Management Group and VP Finance at The Absolut Company. Prior to that, Olof Stålnacke held various finance director roles and worked as a management consultant at McKinsey & Co. Olof Stålnacke holds no other Board assignments.

Information about the other proposed Directors is available on the company's website: www.alimakgroup.com.

Election of auditor (item 13)

The Nomination Committee proposes that the registered accounting firm Ernst & Young AB be re-appointed auditor. The proposal of the Nomination Committee corresponds with the recommendation of the Audit Committee. Neither the Nomination Committee's proposal nor the Audit Committee's recommendation has been subject to influence of a third party nor subject to any terms in contract limiting the choice of auditor.

Ernst & Young AB has given notice that if the Nomination Committee's proposal for auditor is adopted at the meeting, Andreas Mast, Authorised Public Accountant, will be the person appointed to have main responsibility for the audit.


Resolution regarding the Nomination Committee (item 14)

The Nomination Committee proposes that the following instructions apply to the Nomination Committee until new instructions are decided:

The Nomination Committee shall consist of representatives of the three to four (3–4) largest shareholders by voting rights in accordance with the shareholder register¹ maintained by Euroclear Sweden AB as of 31 August each year, together with the Chair of the Board, who shall also convene the Nomination Committee to its first meeting. If one (1) or more of the four (4) largest shareholders by voting rights choose not to participate in the Nomination Committee, the right to nominate a representative shall pass to the shareholder with the next largest voting entitlement until the Nomination Committee consists of at least three (3) members. The member representing the shareholder holding the highest percentage of voting rights will have the right to appoint the chair of the Nomination Committee but can choose to transfer this right to another member of the Nomination Committee. If, more than three (3) months before the AGM, any shareholder that has appointed a member of the Nomination Committee is no longer one of the three (3) respectively four (4) shareholders holding the highest percentage of voting rights, the member appointed by that shareholder must stand down, and any shareholder that has then become one of the three (3) respectively four (4) shareholders holding the highest percentage of voting rights will be entitled to appoint one (1) member each. If a member leaves the Nomination Committee before its work is completed, and the Nomination Committee finds it desirable that a replacement be appointed, that replacement shall represent the same shareholder or, if the shareholder is no longer one of the three (3) respectively four (4) shareholders holding the highest percentage of voting rights, the shareholder holding the next highest percentage of voting rights. Changes in membership of the Nomination Committee must be made public immediately.

The identity of Nomination Committee members before each AGM must be made public no later than six (6) months before the AGM. No remuneration is payable to members of the Nomination Committee. The company will pay necessary overheads incurred by the Nomination Committee in its work. The Nomination Committee's term of office runs until the identity of the next Nomination Committee members has been made public.

The Nomination Committee will draw up proposals on the following matters to be decided at the AGM:

a) Proposed chair of the AGM;
b) Proposed number of directors;
c) Proposed directors and Chair of the Board;
d) Proposed fees for directors elected at the AGM who are not employed by the company, divided between the Chair and other directors, and remuneration for committee work, per member;
e) Proposed auditor(s) and auditor's fee; and
f) Where considered necessary, proposed amendments to these instructions for the Nomination Committee.

In performing other aspects of its work, the Nomination Committee must perform the duties incumbent on it under the Swedish Code of Corporate Governance (including accompanying instructions).

RESOLUTIONS PROPOSED BY THE BOARD

¹ The statistics of owners to be used shall be sorted by voting power (owner grouped) and contain the largest shareholders registered as owners in Sweden, i.e. shareholders with an Euroclear Sweden AB account in their own name or shareholders who hold a deposit with a trustee who has provided the shareholder’s identity to Euroclear Sweden AB.


Allocation of the company's results in accordance with the adopted balance sheet and determination of the record day for dividends (item 9.b)

The Board proposes that the distributable profit of MSEK 5,262.6 be allocated as follows. A total dividend of MSEK 349.2 will be paid to the shareholders, equal to SEK 3.3 per share, and that the remaining sum of MSEK 4,913.4 will be carried forward. The proposed record day for dividends is Friday, May 8, 2026. If the resolution is passed at the meeting, it is expected that dividends will be distributed by Euroclear Sweden AB on Wednesday, May 13, 2026.

Resolution on approval of Remuneration Report (item 15)

The Board of Directors proposes that the Annual General Meeting resolves to approve the Board of Directors' report on remuneration pursuant to Chapter 8, Section 53 a of the Swedish Companies Act.

Resolution on guidelines for salary and other remuneration (item 16)

The Board proposes that the general meeting resolves on the following guidelines for salary and other remuneration to directors, President and Chief Executive Officer (CEO), and other senior executives. Senior executives refer to senior executives of the Group Leadership Team. These guidelines will be valid for agreements entered into after the general meeting's resolution and for changes made to existing agreements thereafter. These guidelines do not apply to remuneration decided or approved by the general meeting, for example director fees and share-based incentive programs.

The guidelines' promotion of the Company's business strategy, long-term interests and sustainability

Information about the Group's business strategy can be found in the latest annual report at www.alimakgroup.com.

It is of fundamental importance to the Group and its shareholders that these guidelines, in both a short- and long-term perspective, create good conditions to attract and retain competent senior executives. The purpose of these guidelines is to increase transparency in remuneration issues and through relevant remuneration structures, create incentives for senior executives, to execute strategic plans and deliver effective operational results to support the Group's business strategy and long-term interests, including its sustainability. To obtain this, it is important to sustain fair and internally balanced terms that are at the same time competitive on the market with respect to structure, scope and compensation levels. These guidelines ensure that senior executives, regardless of geographical market, may be offered a competitive total compensation.

Remuneration and forms of remuneration

The terms of employment for senior executives should consist of a balanced combination of fixed remuneration, variable remuneration, pension and other benefits and terms for dismissal/severance payment. Such a combination of compensation fosters and supports management and achievement of objectives in both a short and long-term perspective. The various types of remuneration that may be paid out are described below.

  • Fixed remuneration

The fixed remuneration shall be individually determined and shall be based on each individual's responsibility and role as well as the individual's competence and experience in the relevant position.

  • Variable remuneration

The variable remuneration shall be measured during a period of one year and be structured as a percentage rate of the fixed remuneration. The variable remuneration may be up to 75 percent of the fixed remuneration for the CEO and up to 50 percent for other senior executives.


Variable remuneration must be linked to predetermined and measurable goals that can be financial or non-financial and that promote the Company's long-term and sustainable development. The goal formulation must be designed so that no variable remuneration is paid if a minimum level of performance is not met.

At the end of the annual measurement period, an overall performance evaluation shall be made to determine the extent to which the objectives have been achieved. The Remuneration Committee is responsible for the evaluation with respect to variable compensation to the CEO and other senior executives. With regards to financial objectives, the evaluation shall be based on audited financial information made public by the Group.

  • Pension

The main principle is that pension contributions are based on collective bargaining agreement provisions in each geographical market. On entering into new pension agreements, senior executives entitled to pension will have defined contribution pension agreements based on fixed remuneration. Variable remuneration shall constitute pensionable salary only when necessary to comply with mandatory collective bargaining agreement provisions applicable to the senior executive. Pensioning of senior executives takes place in accordance with the respective country's pension rules.

Pension agreements for the CEO shall be defined contribution based and must not exceed 40 percent of the fixed remuneration.

For employments governed by rules other than Swedish, pension benefits may be duly adjusted for compliance with mandatory rules or established local practice, taking into account, to the extent possible, the overall purpose of these guidelines.

  • Other benefits

Other benefits, such as health and medical insurance must comprise a minor part of the total compensation and must correspond to what may be deemed market practice in each geographical market.

For employments governed by rules other than Swedish, other benefits may be duly adjusted for compliance with mandatory rules or established local practice, taking into account, to the extent possible, the overall purpose of these guidelines.

  • Special remuneration

Further special remuneration may be awarded for extraordinary arrangements provided that they are limited in time and are awarded on an individual basis. Examples of situations where special remuneration may be awarded are to recruit or retain executives, as remuneration for extraordinary performance beyond the individual's ordinary tasks and to induce individuals to move to new places of service or accept new positions. Any resolution on such remuneration shall be made by the Board based on a proposal from the Remuneration Committee.

Long-Term incentive programs

The general meeting can and has for a number of years, in addition to and independently of these and previous guidelines, decided on long-term incentive programs.

For more information about these programs, see the respective year's notice of the Annual General Meeting.

Terms for dismissal etc.


Terms for dismissal and severance pay shall correspond to what may be deemed market practice on each geographical market. The CEO has a notice period of six (6) months on his/her part and twelve (12) months on the part of the Company. Between the Company and other senior executives, a mutual notice period of six (6) months normally applies. On entering into new employment agreements, agreement may be made with senior executives on severance pay corresponding to a maximum of twelve (12) months' fixed remuneration. The foregoing applies only to notice given by the Company and, in general, the established practice in each geographical market where the executive works, applies.

Remuneration payable to Directors

In certain cases, Directors elected by the general meeting, should be able to receive fees and other remuneration for work carried out on behalf of the Group, in addition to their Board work. Fees for such work shall be at market terms and are subject to approval by the other Board members.

No remuneration shall be paid to the Group's employees acting as directors on the boards of Group companies.

Remuneration and employment conditions for other employees

In the preparation of this proposal for guidelines, remuneration and employment conditions for employees of the Company have been taken into account by collecting information on the employees' total income, the components of the remuneration and increase and growth rate over time.

The decision-making process to determine, review and implement the guidelines

The Board resolves, after preparation by the Remuneration Committee, on the structures of remuneration systems, as well as levels and forms of remuneration to senior executives. The Board shall prepare a proposal for new guidelines at least every fourth (4) year and submit it to the general meeting for adoption. The guidelines shall be in force until new guidelines are adopted by the general meeting. The Remuneration Committee shall monitor and evaluate programs for variable remuneration for the Group executive management, the application of the guidelines as well as the current remuneration structures and compensation levels in the Group.

The members of the Remuneration Committee are independent of the Group and the executive management of the Group. The CEO and other members of the Group executive management do not participate in the Board's processing of and resolutions regarding remuneration-related matters in so far as they are affected by such matters.

Derogation from the guidelines

The Board may temporarily resolve to derogate from the guidelines, in whole or in part, if in a specific case there is special cause for the derogation and a derogation is necessary to serve the Company's long-term interests, including its sustainability, or to ensure the Company's financial viability. As set out above, the Remuneration Committee's tasks include preparing the Board's resolutions in remuneration-related matters. This includes any resolutions to derogate from the guidelines.

Miscellaneous

Total remuneration and other benefits paid to senior executives during the year are disclosed in the annual report.

Resolution on call option program 2026 (item 17)


The Board proposes that the Annual General Meeting adopts a call option program 2026 for the CEO, members of the group management, executive management in the divisions and certain employees at the group functions. The call option program will comprise a maximum total of 65 participants in the Alimak Group and the terms of the call options will be based on market terms following established models at the time of issue.

The Annual General Meeting is proposed to authorise the Board to issue, until the next Annual General Meeting, call options for 1,075,000 shares maximum, corresponding to 1.0 percent of the total number of shares and votes at the time of issue of the notice to the Annual General Meeting 2026.

The CEO will be offered a maximum of 100,000 call options. The remaining 975,000 call options will be offered to members of the group management, executive management in the divisions and certain employees at the group functions. The total number of participants in this category is 64 and each participant may be offered to buy call options in the range 2,000–40,000. Each participant’s individual allocation within the specified range is based upon criteria such as the respective participant’s role, experience and competence.

If there are remaining call options following the initial subscriptions of the call options offered to the participants, the remaining call options may be distributed among the participants irrespective of category. However, participants may not be allotted more than twice the number of call options compared to the initial offered allotment. The total number of call options may however never exceed 1,075,000. The Board resolves on the final allotment.

The call option program does not involve any dilution for existing shareholders as it is based on call options in respect of shares already issued in the company.

The terms of the call options will be based on market terms following established models. The option premium will be 10.0 percent of the recorded volume weighted average share price during ten (10) days prior to the date of issue. The call options will have maximum four (4) years maturity from the date of issue and the subscription period will be May 20 – June 20, 2030. The exercise price per share will be determined by an independent valuer when the call option program is established and will always be an amount above the share price at the same time. The valuation will be performed using the Black & Scholes model.

At the time of the notice of the Annual General Meeting 2026, the company owns 1,739,911 repurchased shares, which refer to previous years’ call option programs. This means that if the call option program 2026 is fully subscribed, Alimak Group AB needs to buy back 1,075,000 shares to ensure delivery of shares for this program. Notwithstanding participation in the call option program, and due to that no new shares are issued, the company’s share capital remains unchanged.

The purpose of the Board’s proposal is that the call option program is expected to contribute to higher motivation and long-term commitment among the employees as well as strengthen the ties between the employees and the company. Furthermore, the Board assesses that the call option program will contribute to recruit and retain qualified and experienced employees. It is the Board’s assessment that the call option program will benefit both the employees and the company’s shareholders through increased share value.

The proposal is a part of creating a long-term incentive for important employees. The proposal is considered to be of reasonable scope for employees and Alimak Group AB’s shareholders. It is the intention of the Board to return to similar propositions at the coming Annual General Meetings.

The company will support and compensate the participants for part of the price they pay to acquire the call options. Thus, each participant will receive a salary payment that, before taxes, corresponds to 50


percent of the purchase price of the call options. This compensation only applies to call options from the initial offering, not to call options subscribed in any subsequent allotments.

Since the program is based on market terms and since it entails a financial risk for the participants, it is not expected to generate social security costs for the company, except those related to the compensation. The total cost of the compensation is estimated to MSEK 5.3, including social security contribution costs. Furthermore, Alimak Group AB will have limited costs relating to advisors and administration of the call option program.

To ensure delivery of shares under the call option program it is proposed, by item 18.c) on the agenda, that the Board shall have the right to transfer a maximum of 1,075,000 repurchased shares to the participants in the call option program. Should that proposal not be supported by the required majority, it is proposed that the Board shall be entitled to enter into so-called share swap agreements with third parties to fulfil the obligations under the call option program.

Alimak Group AB currently has four (4) outstanding incentive programs in the form of call option programs (call option program 2022, 2023, 2024 and 2025). The four (4) call option programs were offered in these years to the CEO, members of the group management, executive management in the divisions and certain employees at the group functions. The terms and conditions of the call options were established in accordance with the framework adopted by the Annual General Meetings held in 2022, 2023, 2024 and 2025. Please refer to the Alimak Group's annual report 2025 and the company's website for a description of the company's long-term incentive programs.

The proposal has been prepared by the Remuneration Committee and was discussed at the Board meeting in March 2026.

Resolution on authorisation for the Board to resolve on acquisition of own shares (item 18.a)

The Board proposes that the meeting authorises the Board to resolve on acquisition of own shares on one or several occasions during the period up to the next Annual General Meeting in accordance with the following.

  1. Acquisition of own shares may be made by an offer extended to all shareholders or on Nasdaq Stockholm.
  2. Own shares may be acquired to the extent the company's holdings of own shares in total amounts to no more than 10.0 percent of all shares in the company.
  3. Acquisition of own shares on Nasdaq Stockholm shall be made in cash and at a price not higher than the higher of the prices for the most recent independent trade and the highest current independent bid on the trading venue where the purchase is made. Purchases may not be made at a price lower than the lowest price at which an independent purchase may take place.

The reasons for the proposed authorisation to repurchase own shares are to adjust the company's capital structure, create value for shareholders, provide the opportunity to offer own shares as payment in relation to acquisitions, be able to meet commitments under call option programs and to cover the costs of issued call option programs.

The Board has issued its reasoned statement in accordance with Chapter 19 Section 22 of the Swedish Companies Act.

Resolution on authorisation for the Board to resolve on transfer of own shares (item 18.b)

The Board proposes that the meeting authorises the Board to resolve on transfer of own shares on one or several occasions during the period up to the next Annual General Meeting in accordance with the following.


  1. Transfer of own shares may be made either on Nasdaq Stockholm or in another manner.
  2. Transfer of own shares may be made with disapplication from the shareholders' pre-emption rights.
  3. The maximum number of shares that may be transferred is the total number of own shares held by the company at the time of the Board's resolution to transfer the shares.
  4. Transfer of own shares on Nasdaq Stockholm shall be made at a price within the stock market price interval registered at any given time, such interval being the interval between the highest purchase price and the lowest sales price. Transfer of own shares in another manner shall be made at a minimum price that shall correspond with the shares' market value at the time of the Board's resolution to transfer the shares.
  5. Payment for the transferred shares may be made in cash, by contribution in kind or by way of set-off.
  6. The Board will be entitled to determine the other terms and conditions of the transfer which, however, shall be in accordance with the market practice.

The reasons for the proposed authorisation to transfer own shares and for the disapplication from the shareholders' pre-emption rights are to adjust the company's capital structure, create value for shareholders, provide the opportunity to offer own shares as payment in relation to acquisitions and to cover the costs of issued call option programs.

Resolution on transfer of own shares to participants in call option program 2026 (item 18.c)

The Board proposes that the meeting resolves on transfer of own shares in accordance with the following.

  1. 1,075,000 shares may be transferred.
  2. The maximally 65 participants in the call option program 2026 are, with disapplication from the shareholders' pre-emption rights, entitled to acquire the shares with right for each of the participants to acquire no more than the maximum number of shares allowed under the terms and conditions for the call option program. The option price and exercise price follow from the terms and conditions established at the time the call option program 2026 was established and determined by an independent valuer using the Black & Scholes model.
  3. The shares shall be transferred within the time period May 20 – June 20, 2030.
  4. The number of shares and the exercise price of a (1) share may be recalculated due to bonus issue, share split, rights issue and similar events in accordance with the terms and conditions of the call option program.

The reason for the proposed transfer and for the disapplication from the shareholders' pre-emption rights is to enable delivery of shares under the call option program 2026.

The Board proposes that a resolution under this proposal is to be subject to the meeting having resolved to pass the Board's proposal on call option program 2026 under item 17 on the agenda.

SPECIAL MAJORITY REQUIREMENT

For resolutions according to items 18.a) (authorisation on acquisition of own shares) and 18.b) (authorisation on transfer of own shares), to be valid, each proposal must be supported by shareholders holding at least two thirds (2/3) of the votes cast as well as of the shares represented at the meeting. For a valid resolution under item 18.c) (resolution on transfer of own shares to participants in call option program 2026), the proposal must be supported by shareholders holding at least nine tenths (9/10) of both the votes cast and the shares represented at the meeting.

DOCUMENTS

The Board's and Nomination Committee's complete proposals, including the Board's and auditors reports, as well as the accounting documents and the auditor's report for 2025, will be available at the


company and on the company's website www.alimakgroup.com as from no later than Wednesday, April 15, 2026, and will be sent immediately without charge to any shareholder who so request and state their postal address. The documents will also be available at the meeting.

NUMBER OF SHARES AND VOTING RIGHTS

The total number of shares in the company as of the date of this notice is 107,573,111 shares, representing a total of 107,573,111 voting rights. As of the day per this notice the company owns 1,739,911 of its own shares.

INFORMATION AT THE MEETING

If any shareholder so request and the Board considers it possible without material harm to the company, the Board and the CEO must provide information at the meeting on any circumstances that may influence determination of an item on the agenda, circumstances that may influence determination of the financial position of the company or any of its subsidiaries, the group accounts and the company's relationship to another group company. Any shareholder wishing to submit questions in advance may do so to Johnny Nylund, by post to the address Alimak Group AB, Blekholmstorget 30, 111 64 Stockholm or by e-mail to the address [email protected].

PROCESSING OF PERSONAL DATA

For information on how your personal data is processed, please see https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf.

Stockholm in March 2026

Alimak Group AB (publ)

The Board of Directors

For more information, please contact:

Johnny Nylund, CCO Alimak Group, +46 76 852 5759

[email protected]

About Alimak Group

Alimak Group is a global provider of sustainable vertical access and working at height solutions, listed on Nasdaq Stockholm. With a presence in more than 120 countries, the Group develops, manufactures, sells and services vertical access and working at height solutions with a focus on adding customer value through enhanced safety, higher productivity and improved cost efficiency. The Group has a large installed base of elevators, service lifts, temporary and permanent hoists and platforms and building maintenance units around the world. The solutions portfolio also comprises height safety protective equipment, load measurement & control, lifting & handling, and a global after-sales business model, with recurring revenue from spare parts and services such as inspection, certification, maintenance, refurbishments, replacements and training. Founded in Sweden in 1948, the Group has its headquarters in Stockholm, 26 production and assembly facilities in 15 countries and approximately 3,000 employees. corporate.alimakgroup.com